StockData
UroGen Pharma Ltd. logo

UroGen Pharma Ltd. (URGN) stock

URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$29.79−0.08 (-0.27%)

Close on Nov 18, 2026Market cap $1.46BP/E –Yield –

UroGen Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

UroGen Pharma's market cap was $1.28B on Nov 11, 2026, against $1.35B a year earlier. Over the last 5 years it ranged from $120.67M to $2.11B, with a median of $491.58M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.28B+16.4%
2025Dec 31, 2025$1.10B+143.8%
2024Dec 31, 2024$449.33M-29.0%
2023Dec 29, 2023$633.00M+210.1%
2022Dec 30, 2022$204.11M-4.2%
2021Dec 31, 2021$213.07M-46.4%
2020Dec 31, 2020$397.73M-43.1%
2019Dec 31, 2019$698.91M+0.8%
2018Dec 31, 2018$693.36M+708.1%
2017Dec 29, 2017$85.80M–

More UroGen Pharma figures

See a number that looks wrong?